Bharat Immunologicals (India) Financial Indicators Patterns

BIBCL -- India Stock  

INR 11.63  0.37  3.29%

Please use Bharat Immunologicals fundamental data analysis to find out if markets are presently mispricing the company. We found twenty-three available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Bharat Immunologicals to be traded at 13.96 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with VIVO BIO, Sterling Biotech, Marico, and Wipro. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.

Bharat Immunologicals Earnings Per Share vs Cash and Equivalents

Bharat Immunologicals Biologicals Corp Ltd is rated fourth in earnings per share category among related companies. It is number one stock in cash and equivalents category among related companies .

Bharat Immunologicals Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Bharat Immunologicals correlated with the market. If Beta is less than 0 Bharat Immunologicals generally moves in the opposite direction as compared to the market. If Bharat Immunologicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bharat Immunologicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bharat Immunologicals is generally in the same direction as the market. If Beta > 1 Bharat Immunologicals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Bharat Immunologicals Financial Distress Probability

48%
Chance of Financial Distress
Bharat Immunologicals Biologicals Corp Ltd has less than 48 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Bharat Immunologicals

Compare Bharat Immunologicals To Peers

Bharat Immunologicals Opportunity Range

December 13, 2018 Opportunity Range

Check also Trending Equities. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Search macroaxis.com